Retatrutide must be dosed diligently, because the dose needs to be enhanced step by step to attenuate side effects. An average starting dose for the initial four months in phase 2 trials is 2mg/7 days. The gradual increase in dosage will have to last for a minimum of 12 months. Because there is no accepted label, abide by Recommendations out